G. Chen — Bristol-Myers Squibb (United States)

Area of research

Hepatology · Pathology and Forensic Medicine

Research interest

Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, Cancer Immunotherapy and Biomarkers, and Colorectal Cancer Treatments and Studies.

h-index

citations

704

works

NIH funding

—

primary concept

Hepatocellular carcinoma

✉ Find email ↗

Recent publications

LBA-3 CheckMate 459: Long-term (minimum follow-up 33.6 months) survival outcomes with nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma

Annals of Oncology 2020cited by 58position: middledoi

CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

Annals of Oncology 2019cited by 646position: middledoi

Grants

Collaborative Research: SusChEM: Rational Design of Non-precious Metal Catalysts for a Future Biorefining Industry

NSF1566104$299,9992016–2020PIRePORTER

Alternative Electrocatalysts for Hydrogen and Methanol Fuel Cells

NSF0518900$294,9992005–2009PIRePORTER

U.S.-China Cooperative Research: Study In Bimetallic Catalysis Between University of Delaware and Peking University

NSF0321942$40,8002003–2007PIRePORTER

2002 Gordon Research Conference on Catalysis

NSF0210083$8,0002002–2003PIRePORTER

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Hepatology · Pathology and Forensic Medicine →